Psychobiological problems in heavy ‘ecstasy’ (MDMA) polydrug users
- 1 July 2000
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 60 (1), 105-110
- https://doi.org/10.1016/s0376-8716(00)80013-7
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Memory deficits associated with recreational use of "ecstasy" (MDMA)Psychopharmacology, 1999
- Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beingsThe Lancet, 1998
- The psychobiology of MDMA or 'ecstasy': Symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997Journal of Psychopharmacology, 1998
- Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological EffectsHuman Psychopharmacology: Clinical and Experimental, 1997
- Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ???Ecstasy???)Drug Safety, 1996
- Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)Psychopharmacology, 1995
- Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in HumansNeuropsychopharmacology, 1994
- MDMA (Ecstasy) precipitation of panic disorderBiological Psychiatry, 1992
- Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?The American Journal of Drug and Alcohol Abuse, 1992
- Neuropsychological assessment substance abusers: Review and recommendationsJournal of Substance Abuse Treatment, 1985